research Telogen effluvium in SARS‐CoV‐2 infection: Histological aspects
COVID-19 can cause a temporary hair loss condition.
Search
for
Sort by
Research
270-300 / 1000+ results 
research Hair transplantation: A brief review
Hair transplantation is an effective hair loss treatment with two main techniques, requires careful planning, and can improve beard and eyebrows appearance.
research The role of sleep in telogen effluvium and trichodynia: A commentary in the context of the current pandemic
Poor sleep during the pandemic may increase stress and worsen hair loss conditions.
research Engineered extracellular vesicles for tissue repair and regeneration
Engineered extracellular vesicles can improve tissue repair and regeneration.
research Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.
research Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
Finasteride use may increase suicidality risk, especially in young men.
research The JAK/STAT signaling pathway: from bench to clinic
The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.
research 5-alpha reductase inhibitors use in prostatic disease and beyond
5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.
research Medicinal Plants for Managing Post-COVID-19 Complications
Medicinal plants might help with post-COVID-19 issues, but more research is needed.
research Post-COVID Clinical Manifestations in Non-Hospitalized Patients with COVID-19: A Retrospective Cohort Study
Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.
research Evaluation of the effects of COVID‐19 pandemic on hair diseases through a web‐based questionnaire
The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.
research AB1511 SLE ONSET POST COVID-19 VACCINATION: COINCIDENTAL OR ASSOCIATION?
It's unclear if COVID-19 vaccination causes SLE; more research is needed.
research The Impact of COVID-19 Pandemic and Lockdown on Alcohol Consumption: A Perspective From Hair Analysis
Overall alcohol consumption decreased during lockdown, but heavy drinkers consumed more.
research Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Long COVID is complex, affects many survivors, and needs more research for effective treatments.
research A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: Ongoing symptomatic phase vs. post-COVID-19 syndrome
Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.
research Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.
research Hair Root Dermoscopy from Shed Hair: A Simple Diagnostic Tool in Telogen Effluvium
Hair root dermoscopy is a simple, noninvasive tool to diagnose telogen effluvium.
research ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.
research Skin challenges in COVID-19 pandemic: The importance of cosmeceuticals
Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.
research Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.
research Baricitinib: From Rheumatoid Arthritis to COVID‐19
Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.
research Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.
research The most recent advances in understanding and managing hidradenitis suppurativa
Better understanding and new treatments for hidradenitis suppurativa are emerging, but more research is needed.
research Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
Long COVID causes lasting symptoms and needs ongoing care.
research Post COVID complications
COVID-19 survivors may face long-term health issues affecting both mind and body.
research Clinical features, therapeutic outcomes and recovery period of long COVID
Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.
research Prevalence of Long COVID Syndrome and its Association With Blood Group: A Cross-Sectional Study
Long COVID is more common in those with severe initial infections, but not linked to blood group.
research The Role of Neurorehabilitation in Post-COVID-19 Syndrome
Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.
research The Efficient Pre- and Post-Operative Healthcare Strategies for Sleeve Gastrectomy Patients
Effective pre- and post-operative care is crucial for better outcomes in sleeve gastrectomy patients.
research Incidence and probable risk factors of post COVID syndrome among COVID-19 patients in urban population of North Kerala: a 6 months cohort study
Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.